Clinical Trial Update: Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies [Phase 4]

View source ↗

Summary

Phase 4 expanded-access study update for pasireotide shows completed status with results posted, enabling access for eligible patients in Novartis-sponsored stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Cushing Disease

Drugs mentioned

• Signifor (pasireotide) (pasireotide)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Cushing's Disease, Acromegaly | Phase 4 | Status: COMPLETED | Results posted: 2024-08-28